Dr. Sarah Svenningsen, McMaster University, Hamilton, ON

Novel pulmonary CT and MRI biomarkers of airways disease relevant to the clinical understanding, decision making, and therapy guidance of severe asthma will be introduced, and recent scientific literature will be reviewed.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Describe and interpret novel CT and functional MRI biomarkers of asthma;
  • Understand the contributors to ventilation defects visualized by MRI in asthma and their clinical relevance; and
  • Understand the potential role of pulmonary imaging in asthma clinical decision making and therapy guidance.